Updates

Quixant- Trading materially ahead of expectations

November 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Quixant, another expected to “materially exceed expectations,” has announced that it now expects to report full year results ahead of market expectations with revenues in excess of US$115m and pretax profit of >US$10m. Prior to the statement the consensus was for revenue of US$109.5m and adjusted profit before tax of US$8.8m.The strong trading is down to ongoing buoyant customer demand, continued recovery in gross margins and ongoing management of supply risk. The strategy that management has in place across the group is delivering, as it launches new products, diversifies revenue and becomes more closely integrated within customers’ value-chains. Buy on a two year view. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Victoria

Luceco

Quixant (April 2023)

Quixant - Dual catalyst story (October 2021)

Quixant (May 2019)

Quixant - Set to revitalise Densitrons margin (April 2017)

Quixant (January 2017)

Quixant (August 2016)

Quixant - On course to double sales this year (April 2016)

Quixant - Attractive new issue (July 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X